Slideshow

Endo News Roundup: Diabetic Retinopathy

Author(s):

April news highlights the importance of timely eye examinations in young patients with diabetes and the efficacy of a teleretinal screening program.

New studies in diabetes highlight the use of real-time continuous glucose monitoring in type 1 diabetes mellitus (DM) to reduce hemoglobin A1c (HbA1c), primarily in those over age 15 years; how a teleretinal diabetic retinopathy screening program can reduce wait times for screening and improve timeliness of needed care; and note that many young diabetes patients who have health insurance do not receive timely eye examinations to monitor for diabetic retinopathy.

Related Videos
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
© 2024 MJH Life Sciences

All rights reserved.